Tempus AI leverages AI for treatment decisions and diagnostics, thriving in the booming healthcare AI market with strong ...

Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately ...

Dr Anurag Agrawal believes AI has the potential to revolutionise healthcare, particularly in training and education, by using ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...

The use of biomarkers in medicine is transforming the way we detect diseases and develop treatments. Biomarkers are ...

Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has partnered with BioTuring, developer of advanced bioinformatics ...

The Icahn School of Medicine at Mount Sinai has launched the Center for Artificial Intelligence (AI) in Children's Health, ...

The Icahn School of Medicine at Mount Sinai has launched the Center for Artificial Intelligence in Children’s Health. Photo courtesy ...

Barriers to wider use of AI in oncology include inaccuracy, workflow challenges, environmental impacts, and more.

Cloudfiniti, has partnered with three leading Artificial Intelligence (AI) startups, including one based in Europe.

At the same time, Keith Meister, managing partner and chief investment officer of the hedge fund Corvex Management, will take ...

The Ontario Brain Institute (OBI) is pleased to announce a joint new initiative with EpiSign Inc., paving the way for improved diagnosis and care for people with rare neurological genetic disorders.